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Abstract To elucidate a role of glucokinase in hepatic glucose 
metabolism, we overexpressed hexokinase I (I-IKI), liver type 
glucokinase (LGK), or 13 cell type glucokinase (13GK) in primary 
rat hepatocytes using a recombinant adenovirus vector system. 
Overexpression of HKI and LGK induced a 34- and 25-fold 
increase, respectively, in glucose phosphorylation activity meas- 
ured in cell homogenates. While HKI overexpression induced 
only a 1.3-fold increase in glucose oxidation, LGK overexpres- 
sion increased glucose oxidation by 2.9-fold. Overexpression of 
ISGK had essentially the same effect as LGK. The results indicate 
that glucokinase does indeed regulate the rate of hepatic glucose 
oxidation and that the liver-specific sequence of this enzyme is 
not essential for this function. 
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I. Introduction 
Glycolysis in the liver plays an important role in glucose 
metabolism in humans and other mammals. Although most 
glycolytic reactions are reversible, three are markedly exer- 
gonic and therefore considered physiologically irreversible. 
These reactions are those catalyzed by glucokinase (GK; EC 
2.7.1.2), 6-phosphofructo-l-kinase (PFK), and pyruvate ki- 
nase (PK) and are the major sites of regulation of glycolysis 
in the liver [1]. The first step in glycolysis is catalyzed mainly 
by GK, hexokinase isozyme type IV, which can be distin- 
guished from other hexokinases by a number of features in- 
cluding its low affinity for glucose and lack of inhibition by 
glucose 6-phosphate [2]. 
GK gene mutations were recently observed in diabetic pa- 
tients, especially in a subset of diabetes mellitus, maturity 
onset diabetes of the young (MODY) [3-5]. In patients with 
GK gene mutations, the insulin secretory response to glucose 
was impaired [6,7], reflecting GK defects in pancreatic 13cells, 
whereas the contribution of liver GK defects to impaired glu- 
cose metabolism has not been thoroughly investigated in pa- 
tients. Very recent observations using mice lacking liver GK 
or both liver and 13 cell GK suggest that defects in this enzyme 
in pancreatic 13cells play a more significant role in whole body 
glucose homeostasis than do defects in the liver enzyme [8,9]. 
To examine the role of liver type GK in liver glucose me- 
tabolism in vitro, it is preferable to use primary hepatocytes. 
Hepatoma cell lines do not necessarily represent normal he- 
patocytes in many respects including the levels of GLUT2 and 
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GK expression, while hepatocytes i olated with collagenase 
retain many liver functions [10,11]. In the present study, using 
a recently developed adenovirus vector system, we overex- 
pressed either liver type GK (LGK), [3 cell type GK (13GK), 
or hexokinase I (HKI) in primary cultured rat hepatocytes 
and investigated the effects of overexpression f these enzymes 
on glycolysis. Our results indicate that GK plays a crucial role 
in determining liver glucose oxidation capacity and that LGK 
can be replaced by 13GK but not by HKI in the hepatic gly- 
colytic pathway. 
2. Materials and methods 
2.1. Materials 
Collagenase and ethylenediaminetetraacetic id (EDTA) were pur- 
chased from Wako Pure Chemical Industries (Osaka, Japan). Leibo- 
vits L-15 medium and 5-bromo-4-chloro-2-indolyl-[3-D-galactopyrano- 
side were obtained from Sigma Chemical Co. (St. Louis, MO, USA), 
NADP, ATP and glucose 6-phosphate d hydrogenase from Boehrin- 
ger Mannheim (Mannheim, Germany), N-(2-hydroxyethyl)-pipera- 
zine-N'-2-ethanesulfonic acid (HEPES), polyethylene glycol #300 
and dithiothreitol from Nacalai Tesque Inc. (Kyoto, Japan). 0-[6- 
14C]Glucose was obtained from Amersham International p c (Buck- 
inghamshire, UK), NaH[14C]O3 (74-370 MBq/mmol) and Aquasol-2 
from Du Pont-New England Nuclear (Boston, MA, USA). 
2.2. Preparation of recombinant virus containing rat liver type GK 
(AdexlCArLGK), rat ~ cell type GK (AdexlCAr~GK), or 
hexokinase I (AdexlCArHKI) 
Generation of recombinant adenoviruses was performed according 
to the method escribed by Miyake et al. [12]. Briefly, a 1.8 kb frag- 
ment containing the entire coding sequence of rat liver type GK 
cDNA was ligated into a cosmid, pAdexlpCA. The resulting cosmid 
was termed pAdexlpCArLGK. The recombinant adenovirus was then 
prepared by homologous recombination between the pAdexlp- 
CArLGK cosmid and the parental adenovirus type 5 genomic 
DNA-terminal protein complex in the human kidney cell line 293, 
and was termed AdexlCArLGK. Similarly, rat I~ cell type cDNA 
and rat hexokinase I cDNA were used for preparation of Adexl- 
CArl3GK and AdexlCArHKI, respectively. Construction of Adexl- 
CAIacZ was performed as described previously [13]. The recombinant 
adenovirus stocks of AdexlCArLGK, AdexlCArI~GK, AdexlCArH- 
KI, and Adexl CAlacZ had titers of 2.5 × 107, 2.7 × 107, 2.7 × 109, and 
6× 10 s pfu/ml, respectively. 
2.3. Hepatocyte isolation and adenovirus infection 
Hepatocytes were isolated from a male Wistar rat (200 g) by col- 
lagenase digestion as described previously [14]. Isolated hepatocytes 
were seeded in 6 cm collagen-coated culture dishes at a density of 
1.25 × 106 cells/5 ml in L-15 medium (11 mM glucose) and maintained 
at 37°C in humidified 5% CO2 and 95% air. After the hepatocytes had 
attached to the dishes (4 h later), the medium was replaced with 1 ml 
of L-15 medium and the following amounts of recombinant adeno- 
virus stocks were added to the cells: 100 gl of AdexlCArI3GK, 50 gl 
of AdexlCArLGK, 2 gl AdexlCArHKI, or 50 I.tl AdexlCAlacZ. 
After incubation for 1 h with adenovirus at 37°C, the medium was 
removed and the hepatocytes were washed with phosphate-buffered 
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saline (PBS). The hepatocytes were then incubated with 5 ml/dish of 
fresh L-15 medium. The experiments were performed 24 h after the 
isolation of hepatocytes. 
2.4. Assays of GK, HKI and ~GAL expression 
GK and HKI expression were evaluated by direct measurement of 
enzyme activities. 20 h after virus administration, hepatocytes were 
collected and homogenized in 1 ml of a homogenization buffer (20 
mM Tris, pH 7.4, 50 mM KCI, 5 mM MgCI~, 2 mM EDTA, 1 mM 
dithiothreitol, 1% polyethylene glycol #300). Homogenates were cen- 
trifuged at 10 000 × g for 5 rain in a microcentrifuge. HKI activity in 
the supernatant was measured at 0.5 mM glucose as described pre- 
viously [15-17] using 20 ~tl of homogenate in the total volume of 1.5 
ml of assay buffer (20 mM HEPES, pH 7.45, 0.1 M KC1, 0.5 mM 
NADP, 5 mM ATP, 7.5 mM MgC12, 0.4 units of glucose 6-phosphate 
dehydrogenase). GK activity was represented by the difference be- 
tween glucose phosphorylating activity measured at 100 mM and 
0.5 mM glucose. 
For analysis of lacZ gene expression, hepatocytes were washed 
once with PBS, fixed in 3.4% formaldehyde in PBS, and then washed 
three times with PBS over 30 min. Expression of the introduced 
lacZ gene was demonstrated by staining the fixed cells at 37°C for 
8 h in a chromogenic solution containing 5 mM KaFe(CN)6/ 
K4Fe(CN)6.3H20, 2 mM MgCI2, and 1 mg/ml 5-bromo-4-chloro-2- 
indolyl-15-D-galactopyranoside in PBS [18]. The efficacy of gene trans- 
fer was determined by counting clear and blue cells in three separate 
dishes in three independent experiments. 
2.5. Glucose oxidation measurements 
Hepatocytes transfected with GK, HKI or I3GAL cDNA in the 
culture dishes were placed in sealed glass containers (7 cm in diame- 
ter× 10 cm in height) filled with 100% oxygen. D-[6-14C]Glucose was 
added to 2 ml of L-15 medium and the cells were incubated with 11 
mM glucose for 2 h at 37°C. At the end of incubation, 0.5 ml of 10% 
HC104 was added to the medium using a long 21-gauge syringe needle 
through rubber stoppers, allowing CO2 gas (containing [14C]O2) to 
evaporate and be trapped in 2 rnl of 10% KOH solution in a small 
glass cup suspended above the medium in the sealed glass container 
[19]. The glass containers were incubated for another 30 min, then 
KOH solution was transferred to the scintillation vials containing 10 
ml of Aquasol-2, and the radioactivity was measured with a liquid 
scintillation counter. In this system, 92.5 +_ 1.6% (mean + S.D., n = 3) 
of CO2 gas evaporated from the medium containing 0.5 ~tCi (18.5 
kBq) NaH[14C]O3 was trapped in KOH solution. 
2.6. Statistical analysis 
Data are presented as means + S.D. The statistical significance of 
differences between mean values was assessed using Student's t test. 
3. Results 
3.1. Efficient gene transfer and expression using the recom- 
binant adenovirus ystem in primary rat hepatoeytes 
When the [SGAL gene was transferred into primary hepa- 
tocytes by recombinant adenovirus (AdexlCAlacZ) infection 
at a multiplicity of infection (m.o.i) of 24.0, intense blue stain- 
ing with X-gal was observed in the cytoplasm of all hepato- 
cytes 20 h after viral infection (Fig. 1A). Essentially 100% 
efficiency of gene transfer was also demonstrated at a lower 
Table 1 
Glucose phosphorylating activity in hepatocytes 
m.o.i, of 2.4 (data not shown). No blue staining with X-gal 
was observed in hepatocytes which had not been treated with 
AdexlCAlacZ (Fig. 1B). No apparent changes in either num- 
bers or morphological features were observed in hepatocytes 
remaining attached to the culture dishes 20 h after viral infec- 
tion with AdexlCAlacZ, as compared with untreated cells. 
The integrity of infected hepatocytes was also confirmed by 
the observation that the glucose phosphorylation activities 
measured at 0.5 and 100 mM, in AdexlCAlacZ-infected he- 
patocytes, were the same as those in untreated hepatocytes 
(Table 1). 
3.2. The effects of  adenovirus-mediated overexpression f LGK 
or HKI on glucose phosphorylation and glucose oxidation 
In a series of experiments designed to compare the effects of 
hexokinase I overexpression with that of liver type GK over- 
expression, primary hepatocytes were infected with a 50 ~tl 
solution of Adex lCArLGK or a 2 ~tl solution of AdexlCAr-  
HKI.  GK  activity, which was represented by the difference 
between glucose phosphorylating activity measured at 100 
mM and 0.5 mM glucose, was increased approximately 21- 
fold in the cell homogenates, as compared to the activity in 
untreated hepatocytes or AdexlCAlacZ-infected hepatocytes. 
Infection with Adex lCArHKI  resulted in a marked increase, 
of 160-fold on average, in the HK I  activity measured at 0.5 
mM glucose (Table 1). In these infected hepatocytes, glucose 
oxidation measured by conversion of D-[6-14C]glucose to 
[14C]O2 was increased 2.9-fold (2.94+0.14, mean+S.D. ,  
n = 3) in cells overexpressing liver type GK as compared to 
control AdexlCAlacZ-infected cells. In contrast, HK I  over- 
expression induced only a very modest increase, 1.3-fold 
(1.25 + 0.04, mean + S.D., n = 3, P < 0.05), in glucose oxida- 
tion (Fig. 2). Glucose phosphorylating activity measured at 
11 mM, the concentration used also to examine glucose oxi- 
dation, in a cell homogenate of hepatocytes overexpressing 
HK I  was increased 34-fold as compared to that of controls 
(533 + 52 vs. 16 + 2 nmol/min mg protein, mean + S.D., n = 3). 
This value was actually greater than that in hepatocytes over- 
expressing liver type GK (397+ 37 nmol/min mg protein, 
n = 3, a 25-fold increase as compared to that of controls). 
3.3. The effects of adenovirus-mediated overexpression f [$GK 
or LGK on glucose phosphorylation and glucose oxidation 
In another set of experiments, hepatocytes were infected 
with Adex lCArLGK or AdexlCArI3GK to compare the ef- 
fects of LGK overexpression with those of 13GK overexpres- 
sion. Infection with 100 ~tl of AdexlCArI~GK solution in- 
duced an approximately 14-fold (13.5 + 1.6, n = 3) increase in 
the GK activity and a 2.5-fold (2.51 +0.17, n = 3) increase in 
oxidation of 11 mM glucose. Similarly, infection with 50 ~tl of 
Hexokinase activity (nmol/min mg protein) Glucokinase activity (nmol/min mg protein) 
Untreated 3.30 + 0.67 25.8 + 3.4 
Adex 1CAIacZ 3.10 + 0.70 27.0 + 3.7 
Adex 1CArHKI 502 + 81 ND 
Adexl CArLGK ND 566 + 51 
Hepatocytes were isolated and treated with the indicated adenovirus or left untreated. Hexokinase activity was defined as the glucose phosphor- 
ylating activity measured at 0.5 mM glucose. Glucokinase activity was defined as the difference between glucose phosphorylating activity measured 
at 100 mM and 0.5 mM glucose as described in Section 2. Data are means + S.D. of three independent experiments each performed in triplicate. 
ND: not determined. 
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Fig. 1. 13-Galactosidase expression i isolated hepatocytes treated with AdexlCAlacZ recombinant adenovirus. A: Light microscopic view of re- 
presentative primary cultured hepatocytes 20h after infection with AdexlCAlacZ (24 h after isolation). Hepatocytes were treated with chromo- 
genic substrate as described in Section 2. B: Control hepatocytes similarly treated with a choromogenic substrate without previous exposure to 
AdexlCAlacZ recombinant adenovirus. 
AdexlCArLGK solution induced an approximately 15-fold 
(14.5+0.6, n=3) increase in GK activity and a 2.7-fold 
(2.65 + 0.16, n = 3) increase in glucose oxidation (Fig. 3). 
The experiments were also performed using smaller 
amounts of virus. Infection with 8 ~tl of AdexlCAr~GK solu- 
tion induced a 3.4-fold increase in the GK activity and a 1.5- 
fold increase in oxidation of 11 mM glucose. Infection with 2 
/,tl of AdexlCArLGK solution induced a 3.4-fold increase in 
GK activity and a 1.6-fold increase in glucose oxidation. 
Thus, the effects on GK activity apparently paralleled the 
effects on glucose oxidation regardless of whether phosphor- 
ylation activity was increased by overexpression f liver type 
GK or 13 cell type GK. It is not clear why the same volume of 
AdexlCArLGK stock solution exerted a smaller effect on GK 
activity in the latter than in the former series of experiments. 
However, the latter series of experiments were performed 2
months later than the former, such that the infective potency 
of the virus may have diminished uring the storage period. 
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4. Discussion 
Our results demonstrated clearly that gene transfer via re- 
combinant adenovirus is highly effective in primary cultured 
rat hepatocytes. LacZ gene expression was observed in essen- 
tially 100%0 of primary hepatocytes infected with AdexlCA- 
lacZ. Similarly, a very high efficiency (86%) of muscle glyco- 
gen phosphorylase g ne expression was previously obtained in 
isolated rat hepatocytes u ing an adenovirus vector [20]. Gene 
transfer via a retrovirus vector is not effective in non-prolif- 
erating cells including primary hepatocytes. Physical gene 
transfer methods uch as those using liposomes and electro- 
poration are at present rather inefficient methods of gene 
transfer, requiring subsequent cloning of the transfected cells 
which is not possible in primary hepatocytes. Infection with 
AdexlCAlacZ induced neither apparent morphological 
changes on light microscopic examination nor changes in glu- 
cose phosphorylating activity (Table 1) and the glucose oxida- 
tion rate (data not shown), as compared to uninfected cells. 
These observations indicate that adenovirus infection per se 
does not alter hepatocyte functions o long as virus titers are 
within the ranges used in this study. 
Utilizing gene transfer and expression with an adenovirus 
vector, we were able to directly manipulate the GK gene ex- 
pression in primary rat hepatocytes. We thereby demonstrated 
that GK is indeed a key enzyme determining the glucose oxi- 
dation rate in hepatocytes. This is consistent with very recent 
observations of hepatocytes i olated from the mice lacking 
GK gene expression [8,9]. In addition, we also demonstrated 
that an increase in GK gene expression o more than tripled 
overall glucose oxidation in primary rat hepatocytes. A dis- 
crepancy between the large increase, induced by overexpres- 
sion of the enzyme, in glucose phosphorylation activity and 
the relatively small increase in glucose oxidation has also been 
reported in pancreatic islets and a pancreatic ~cell line MIN6 
[21,22]. We suggested that some step(s) other than glucose 
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Fig. 2. Glucose oxidation in primary cultured hepatocytes overex- 
pressing hexokinase I and liver type glucokinase. Glucose oxidation 
was measured by following the conversion of D-[6J4C]glucose into 
[t4C]O2 as described in Section 2. Data are expressed as the mean 
fold change + S.D. of three independent experiments each performed 
in triplicate. The absolute values for the control ranged from 0.034 
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Fig. 3. Glucose oxidation and glucose phosphorylating activity in 
primary cultured hepatocytes overexpressing I 3 cell type and liver 
type glucokinase, a: Glucose oxidation was measured 20 h after ex- 
posure to the indicated recombinant adenoviruses, b: Glucokinase 
activity was represented by the difference between glucose phosphor- 
ylating activity measured at 100 mM and 0.5 mM. Data are ex- 
pressed as the mean fold change + S.D. of three independent experi- 
ments each performed in triplicate. 
phosphorylation became rate-limiting for glucose utilization 
in MIN6 cells overexpressing hexokinase I [22]. The present 
results suggest hat this is also the case in rat hepatocytes, 
although it should be kept in mind that the enzyme activity 
was assayed in vitro and CO2 production was assessed in 
intact cells. It is possible that glucokinase regulatory protein 
present in hepatocytes inhibits GK activity, since the level of 
fructose 6-phosphate, a potent activator of glucokinase regu- 
latory protein [23], may be increased by accelerated conver- 
sion of glucose to glucose 6-phosphate. 
The liver type and pancreatic [~ cell type GK differ only in 
the 14-16 amino acids of the amino-terminus which are en- 
coded by tissue-specific leader exons. It has been speculated 
that the amino-terminal domain of glucokinase has a specific 
functional role [24]. However, these two glucokinases exerted 
essentially the same effect on glucose oxidation when over- 
expressed in primary rat hepatocytes, indicating that the li- 
ver-specific amino-terminal sequence of GK is not indispen- 
sable for its function in liver glucose metabolism. 
GK overexpression exerted a greater facilitating effect on 
glucose oxidation than did HKI overexpression i primary 
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hepatocytes, even in the conditions where the effects of GK 
overexpression on glucose phosphorylating activity were smal- 
ler than those of HKI  overexpression. This difference may be 
accounted for at least in part by HKI  being allosterically 
inhibited by the product (glucose 6-phosphate) whereas liver 
GK is not. Very recently, Becker et al. reported that HKI  
overexpression has greater metabolic effects than GK over- 
expression in isolated rat islets [25]. The discrepancy of the 
effects between hepatocytes and islets is of great interest and 
needs further investigation. 
In summary, this is the first report to our knowledge of 
gene transfer into and expression of glycolytic enzymes, 
HKI  and GK, in primary rat hepatocytes. Our results indicate 
that GK regulates the rate of glucose metabolism in the liver 
and that the liver-specific N-terminal sequence is not essential 
for this function. 
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